Frontlight ResearchEarly access
Atrial fibrillation trials in Bosnia & Herzegovina
1 trial · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleApixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation
- Where
- Sarajevo
- Age
- 18 years and over
- People
- 800
- Run by
- Bosnalijek D.D
See details and how to joinNCT07458191